Targeting the PDGF signaling pathway in tumor treatment

CH Heldin - Cell Communication and Signaling, 2013 - Springer
Platelet-derived growth factor (PDGF) isoforms and PDGF receptors have important
functions in the regulation of growth and survival of certain cell types during embryonal …

Myelodysplastic syndromes

L Adès, R Itzykson, P Fenaux - The Lancet, 2014 - thelancet.com
Myelodysplastic syndromes are clonal marrow stem-cell disorders, characterised by
ineffective haemopoiesis leading to blood cytopenias, and by progression to acute myeloid …

A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

J Cools, DJ DeAngelo, J Gotlib, EH Stover… - … England Journal of …, 2003 - Mass Medical Soc
Background Idiopathic hypereosinophilic syndrome involves a prolonged state of
eosinophilia associated with organ dysfunction. It is of unknown cause. Recent reports of …

Involvement of platelet‐derived growth factor ligands and receptors in tumorigenesis

CH Heldin, J Lennartsson… - Journal of internal …, 2018 - Wiley Online Library
Platelet‐derived growth factor (PDGF) isoforms and their receptors have important roles
during embryogenesis, particularly in the development of various mesenchymal cell types in …

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant …

LM Kelly, Q Liu, JL Kutok, IR Williams… - Blood, The Journal …, 2002 - ashpublications.org
FLT3 receptor tyrosine kinase is expressed on lymphoid and myeloid progenitors in the
hematopoietic system. Activating mutations in FLT3 have been identified in approximately …

Genetics of myeloid malignancies: pathogenetic and clinical implications

S Fröhling, C Scholl, DG Gilliland… - Journal of clinical …, 2005 - ascopubs.org
Myeloid malignancies are clonal disorders that are characterized by acquired somatic
mutation in hematopoietic progenitors. Recent advances in our understanding of the genetic …

Eosinophilia: secondary, clonal and idiopathic

A Tefferi, MM Patnaik… - British journal of …, 2006 - Wiley Online Library
Blood eosinophilia signifies either a cytokine‐mediated reactive phenomenon (secondary)
or an integral phenotype of an underlying haematological neoplasm (primary). Secondary …

Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation

X Lu, R Levine, W Tong, G Wernig, Y Pikman… - Proceedings of the …, 2005 - pnas.org
A recurrent somatic activating mutation in the nonreceptor tyrosine kinase JAK2
(JAK2V617F) occurs in the majority of patients with the myeloproliferative disorders …

The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and …

J Gotlib, J Cools, JM Malone III, SL Schrier… - Blood, 2004 - ashpublications.org
Idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL)
comprise a spectrum of indolent to aggressive diseases characterized by unexplained …

A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9

AB Dash, IR Williams, JL Kutok, MH Tomasson… - Proceedings of the …, 2002 - pnas.org
Constitutive activation of tyrosine kinases, such as the BCR/ABL fusion associated with t (9;
22)(q34; q22), is a hallmark of chronic myeloid leukemia (CML) syndromes in humans …